MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
MY ACCOUNT
  • SETTINGS
  • LOGOUT
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • Editor’s Picks
  • SPECIAL SERIES
  • Special Coverage
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • Politics
    • Trump Presidency
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • American Essay Contest
  • China
    • China-US News
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • China Society
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business
    • Companies
    • Economies
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Literature
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film Reviews
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Life & Tradition
    • Inspired
    • Family & Home
    • People
    • Food & Dining
    • Travel
  • Entertainment
    • Film & TV
    • Entertainment News
  • Mind & Body
    • News
    • Aging
    • Fitness & Nutrition
    • Treatments and Techniques
    • Chinese Medicine
    • Mindset
SEARCH
  • Premium
  • US
  • Politics
  • China
  • World
  • Opinion
  • Business
  • Science
  • Life
  • Mind & Body
  • Arts
  • Entertainment
  • Videos
  • Games
  • Livestream
  • SageBook
  • More

Science News

  • French Scientists Find Possible CCP Virus Case From December
    French Scientists Find Possible CCP Virus Case From December
    French researchers said they located a CCP virus patient in the country who contracted the illness in December 2019, about a month before the first reported case. The CCP (Chinese Communist ...
    May 5, 2020BY Zachary Stieber
  • Pfizer Starts Human Trials of Potential CCP Virus Vaccines
    Pfizer Starts Human Trials of Potential CCP Virus Vaccines
    Human trials on potential CCP virus vaccines produced by Pfizer started in recent days, the company announced on ...
    May 5, 2020BY Zachary Stieber
  • Government Researchers Changed Endpoint During Remdesivir Trial
    Government Researchers Changed Endpoint During Remdesivir Trial
    Researchers changed the primary endpoint for a clinical trial testing remdesivir against COVID-19, a shift that provoked concerns ...
    May 4, 2020BY Zachary Stieber
  • Lawmakers Investigate NIH Over Chinese Espionage Aimed at US Medical Research
    Lawmakers Investigate NIH Over Chinese Espionage Aimed at US Medical Research
    Two members of Congress have demanded an explanation from the National Institutes of Health (NIH) over possible Chinese ...
    May 2, 2020BY Ella Kietlinska
  • Clinical Trial Shows Remdesivir Quickened Recovery From COVID-19
    Clinical Trial Shows Remdesivir Quickened Recovery From COVID-19
    A rigorous trial sponsored by the U.S. government showed remdesivir has a clear impact on hospitalization time for ...
    April 29, 2020BY Zachary Stieber
  • Gilead ‘Aware’ of Positive Data From Study of Remdesivir’s Effects Against COVID-19
    Gilead ‘Aware’ of Positive Data From Study of Remdesivir’s Effects Against COVID-19
    Gilead Sciences on Wednesday said it was aware of "positive data" from a study on remdesivir's effectiveness against ...
    April 29, 2020BY Zachary Stieber
  • Part of Kevzara Trial Against COVID-19 Halted
    Part of Kevzara Trial Against COVID-19 Halted
    Half of a trial on the effectiveness of Kevzara against COVID-19 was halted while the other portion will ...
    April 27, 2020BY Zachary Stieber
  • New York Hospitals Studying Heartburn Drug With Hydroxychloroquine Against COVID-19
    New York Hospitals Studying Heartburn Drug With Hydroxychloroquine Against COVID-19
    Some hospitals in New York are conducting a clinical trial testing the efficacy of famotidine, a common heartburn ...
    April 27, 2020BY Zachary Stieber
  • NASA Develops Ventilator, Helmet for COVID-19 Patients
    NASA Develops Ventilator, Helmet for COVID-19 Patients
    NASA developed a new ventilator and a helmet for patients suffering from COVID-19, the disease caused by the CCP ...
    April 25, 2020BY Zachary Stieber
  • No Evidence Recovered COVID-19 Patients Are Immune From Reinfection: WHO
    No Evidence Recovered COVID-19 Patients Are Immune From Reinfection: WHO
    There is no evidence that patients who once had COVID-19 are immune from being infected again by the ...
    April 25, 2020BY Zachary Stieber
  • FDA Warns Against Widespread Use of Hydroxychloroquine to Treat COVID-19
    FDA Warns Against Widespread Use of Hydroxychloroquine to Treat COVID-19
    The Food and Drug Administration (FDA) on Friday warned against the use of hydroxychloroquine or the closely related chloroquine ...
    April 24, 2020BY Zachary Stieber
  • Remdesivir Study Ended Early With No Improvement for COVID-19 Patients
    Remdesivir Study Ended Early With No Improvement for COVID-19 Patients
    An antiviral drug tested against COVID-19 in patients in China did not quicken their improvement or prevent death, ...
    April 23, 2020BY Zachary Stieber
  • Human Trial for CCP Virus Vaccine Begins in UK
    Human Trial for CCP Virus Vaccine Begins in UK
    A clinical trial for a possible CCP virus vaccine began in the United Kingdom on Thursday, researchers said. ...
    April 23, 2020BY Zachary Stieber
  • NIH Panel Recommends Against Using Hydroxychloroquine With Z-Pak to Treat COVID-19
    NIH Panel Recommends Against Using Hydroxychloroquine With Z-Pak to Treat COVID-19
    Doctors and experts on a panel created by the National Institutes of Health are recommending against using hydroxychloroquine, ...
    April 22, 2020BY Zachary Stieber
  • Study Finds No Evidence Hydroxychloroquine Works Against COVID-19
    Study Finds No Evidence Hydroxychloroquine Works Against COVID-19
    A study analyzing the use of hydroxychloroquine in U.S. veterans hospitals found no evidence that the drug, traditionally ...
    April 21, 2020BY Zachary Stieber
  • Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci
    Most Antibody Tests Not Validated, Unclear Whether Recovered People Are Immune to Virus: Fauci
    Most antibody tests circulating among the public aren't validated, Dr. Anthony Fauci said, while also saying it hasn't ...
    April 20, 2020BY Zachary Stieber
  • Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug ...
    April 20, 2020BY Zachary Stieber
  • Sunlight Destroys CCP Virus Quickly: Government Tests
    Sunlight Destroys CCP Virus Quickly: Government Tests
    Government tests show sunlight rapidly destroys the CCP virus, according to a Department of Homeland Security Science and ...
    April 18, 2020BY Zachary Stieber
  • Remdesivir ‘Significantly Reduced’ CCP Virus in Monkeys: NIH
    Remdesivir ‘Significantly Reduced’ CCP Virus in Monkeys: NIH
    An experimental drug called remdesivir "significantly reduced" the CCP virus in monkeys, according to a study released on ...
    April 17, 2020BY Zachary Stieber
  • CCP Virus Vaccine Likely Moving to Phase 2 Soon as Higher Dosing Starts
    CCP Virus Vaccine Likely Moving to Phase 2 Soon as Higher Dosing Starts
    A CCP virus vaccine will likely move to phase 2 testing as soon as safety data comes in ...
    April 14, 2020BY Zachary Stieber
  • Chloroquine Study Involving High Dosage Partially Halted Over Risk of Complications
    Chloroquine Study Involving High Dosage Partially Halted Over Risk of Complications
    Half of a study in Brazil exploring how COVID-19 patients reacted to different levels of chloroquine was stopped ...
    April 13, 2020BY Zachary Stieber
  • No Social Distancing in Space: New Crew Greeted With Hugs
    No Social Distancing in Space: New Crew Greeted With Hugs
    CAPE CANAVERAL, Fla.—Three astronauts flew to the International Space Station on April 9, departing the virus-plagued planet with ...
    April 10, 2020BY The Associated Press
  • Chinese Study Finds Cats Highly Susceptible to CCP Virus
    Chinese Study Finds Cats Highly Susceptible to CCP Virus
    A study published in the American Association for the Advancement of Science on April 8 found that cats can ...
    April 9, 2020BY Katabella Roberts
  • Chernobyl Radiation Back to Normal After Spike at Forest Fire Site
    Chernobyl Radiation Back to Normal After Spike at Forest Fire Site
    Ukrainian authorities said that radiation levels were back to normal after an earlier radiation spike in the restricted ...
    April 7, 2020BY Tom Ozimek
  • Life Found in Rocks Beneath the Ocean Floor Give Scientists Hope of Finding Life on Mars
    Life Found in Rocks Beneath the Ocean Floor Give Scientists Hope of Finding Life on Mars
    When scientists find microbial life thriving in some of the most extreme environments on Earth, it gives them ...
    April 5, 2020BY Wire Service
  • Study: Face Masks Effective in Reducing Virus Detection in Exhaled Breath
    Study: Face Masks Effective in Reducing Virus Detection in Exhaled Breath
    Surgical face masks were effective in reducing the detection of viruses in exhaled breath, suggesting masks may help ...
    April 3, 2020BY Zachary Stieber
  • Northern Territory on Alert for Rabies Outbreak
    Northern Territory on Alert for Rabies Outbreak
    The Australian government has warned the Northern Territory and the Torres Strait communities that they are at risk ...
    April 2, 2020BY Victoria Kelly-Clark
Previous 1 2 3 4 5 … 61 Next
TOP NEWS
  • Video: Facts Matter (Jan. 12): More Censorship Hits America; Trump Advisor Put on “a List”
    NEW By Roman Balmakov
    Video: Facts Matter (Jan. 12): More Censorship Hits America; Trump Advisor Put on “a List”
  • House Votes to Pressure Pence to Invoke 25th Amendment After He Rejected to Do So
    1hr By Janita Kan
    House Votes to Pressure Pence to Invoke 25th Amendment After He Rejected to Do So
  • Google’s Youtube Suspends Trump, Accuses Him of Violating Its Policies
    2hr By Mimi Nguyen Ly
    Google’s Youtube Suspends Trump, Accuses Him of Violating Its Policies
  • Pelosi Names House Impeachment Managers Ahead of Vote
    2hr By Isabel van Brugen
    Pelosi Names House Impeachment Managers Ahead of Vote
  • FBI Received Intelligence About Potential for Violence Before US Capitol Breach
    3hr By Janita Kan
    FBI Received Intelligence About Potential for Violence Before US Capitol Breach
  • Vermont College Revokes Giuliani’s Honorary Degree
    3hr By Ivan Pentchoukov
    Vermont College Revokes Giuliani’s Honorary Degree
  • Video: Parler CEO On Fighting Censorship and Double Standards, and Restoring Free Speech
    6hr By Joshua Philipp, The Epoch Times
    Video: Parler CEO On Fighting Censorship and Double Standards, and Restoring Free Speech
  • Pence Refuses to Invoke the 25th Amendment
    6hr By Mimi Nguyen Ly
    Pence Refuses to Invoke the 25th Amendment
  • Federal Prosecutors Building Seditious, Conspiracy Cases Against Some Capitol Rioters: DOJ
    6hr By Janita Kan
    Federal Prosecutors Building Seditious, Conspiracy Cases Against Some Capitol Rioters: DOJ
  • Trump Celebrates Border Wall, Immigration Achievements in Texas Visit
    8hr By Ivan Pentchoukov
    Trump Celebrates Border Wall, Immigration Achievements in Texas Visit
The Epoch Times
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • Editor’s Picks
  • SPECIAL SERIES
  • Special Coverage
  • LATEST ARTICLES
You deserve to hear the truth.
  • Help Center
  • Subscribe
  • Press Room
  • About Us
  • Contact Us
  • FAQ
  • RSS Feeds
  • Terms of Services
  • Privacy Policy
  • Copyright Policy
  • Digital Newspaper
  • Our Story
36 COUNTRIES, 22 LANGUAGES
  • English
  • Chinese
  • Spanish
  • Hebrew
  • Japanese
  • Korean
  • Indonesian
  • French
  • German
  • Italian
  • Portuguese
  • Swedish
  • Dutch
  • Russian
  • Ukrainian
  • Romanian
  • Czech
  • Slovak
  • Polish
  • Turkish
  • Persian
  • Vietnamese
DOWNLOAD OUR APP
iOS Android
  • US
    • US News
    • US Features
    • Politics
    • Trump Presidency
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • American Essay Contest
  • China
    • China-US News
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • China Society
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business
    • Companies
    • Economies
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Literature
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film Reviews
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Life & Tradition
    • Inspired
    • Family & Home
    • People
    • Food & Dining
    • Travel
  • Entertainment
    • Film & TV
    • Entertainment News
  • Mind & Body
    • News
    • Aging
    • Fitness & Nutrition
    • Treatments and Techniques
    • Chinese Medicine
    • Mindset
Copyright © 2000 - 2021
Back Top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Use. More informationI accept×